DELTA BIOTECHNOLOGY LTD has a total of 332 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are NOVOZYMES DELTA LTD, LFB BIOTECHNOLOGIES and LEDBETTER JEFFREY A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 67 | |
#2 | WIPO (World Intellectual Property Organization) | 35 | |
#3 | EPO (European Patent Office) | 33 | |
#4 | Australia | 30 | |
#5 | United States | 30 | |
#6 | Canada | 28 | |
#7 | South Africa | 22 | |
#8 | Ireland | 13 | |
#9 | China | 12 | |
#10 | Finland | 11 | |
#11 | Japan | 10 | |
#12 | Denmark | 9 | |
#13 | Republic of Korea | 8 | |
#14 | Hungary | 6 | |
#15 | Israel | 4 | |
#16 | Mexico | 3 | |
#17 | Spain | 2 | |
#18 | Hong Kong | 2 | |
#19 | New Zealand | 2 | |
#20 | Singapore | 2 | |
#21 | Brazil | 1 | |
#22 | Germany | 1 | |
#23 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Agriculture | |
#6 | Machines | |
#7 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Enzymes | |
#6 | Fermentation | |
#7 | Reduction of greenhouse gas emissions | |
#8 | Animal care | |
#9 | Unspecified technologies | |
#10 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Sleep Darrell | 83 |
#2 | Hinchliffe Edward | 45 |
#3 | Ballance David James | 33 |
#4 | Goodey Andrew Robert | 31 |
#5 | Johnson Richard Alan | 27 |
#6 | Quirk Alan Victor | 23 |
#7 | Woodrow John Rodney | 21 |
#8 | Berezenko Stephen | 20 |
#9 | Mead David John | 19 |
#10 | Wood Patricia Carol | 17 |
Publication | Filing date | Title |
---|---|---|
GB0512707D0 | Gene expression technique | |
GB0329681D0 | Gene expression technique | |
GB0329722D0 | Modified plasmid and use thereof | |
KR20050065519A | Albumin-fused ciliary neurotrophic factor | |
GB0310347D0 | Assay | |
GB0305989D0 | Agent | |
CA2475382A1 | Albumin-fused anti-angiogenesis peptides | |
GB0217033D0 | Gene and polypeptide sequences | |
GB0202633D0 | Stabilization of protein preparations | |
GB0200816D0 | Chiral selection | |
AUPR977601A0 | Defective entities and uses therefor | |
GB9902000D0 | Process | |
DE19858777A1 | Process for the partial or complete separation of glycosylated and non-glycosylated proteins | |
HK1031734A1 | High purity albumin produced by a multistep process. | |
GB9713412D0 | Improved protein expression strains | |
WO9733973A1 | Fermentation control | |
GB9700027D0 | Fermentation control | |
GB9624247D0 | Yeast promoter | |
GB9605255D0 | Fermentation control | |
WO9731947A1 | High purity albumin production process |